An assay to evaluate the function of liposomal platelet substitutes delivered to platelet aggregates

Suyun Janet Tan, Keiko Nakahara, Keitaro Sou, Shinji Takeoka

研究成果: Article

抄録

Aggregation of liposomal platelet substitutes with activated platelets is the primary endpoint to estimate hemostatic potential. Although light transmission aggregometry is a "gold standard" in assessing platelet aggregation in vitro, this method is less specific and sensitive when tested using liposomal platelet substitutes. In the current study, a new method is developed to evaluate the function of platelet substitutes. By labeling liposomes with a fluorescent dye, DiD, we evaluated their ability to target platelet aggregates using a fluorescence microscope. By incorporating an image-based 96 microtiter microplate, this method was optimized by varying the final lipid concentrations and washing times and validated using unmodified liposomes (e.g., L550 with 0 mol% of carboxylic headgroup lipid; L551 with 9 mol% of carboxylic headgroup lipid) and modified liposomes (e.g., H12-L551 with 9 mol% of carboxylic headgroup lipid and 0.3 mol% of dodecapeptide). Our results showed that 200 μM of H12-L551 liposomes and four washes represent optimal conditions for quantitative fluorescence imaging. This method allowed users to qualitatively observe the fluorescently labeled liposomes involved in platelet aggregates. The imaging analysis tool was sufficiently sensitive to quantitatively determine the significantly enhanced delivery of the modified liposomes to platelet aggregates. This enhancement was achieved using dodecapeptide, which specifically binds to activated platelets. This robust and high-throughput method enables the evaluation of liposome function and should facilitate the development of platelet substitutes with a greater ability to target platelet aggregates.

元の言語English
記事番号77
ジャーナルFrontiers in Bioengineering and Biotechnology
7
発行部数APR
DOI
出版物ステータスPublished - 2019 1 1

Fingerprint

Platelets
Assays
Blood Platelets
Liposomes
Lipids
Platelet Aggregation
Agglomeration
Fluorescence
Optical Imaging
Imaging techniques
Hemostatics
Fluorescent Dyes
Light transmission
Washing
Labeling
Microscopes
Light
Dyes
Throughput

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Histology
  • Biomedical Engineering

これを引用

An assay to evaluate the function of liposomal platelet substitutes delivered to platelet aggregates. / Tan, Suyun Janet; Nakahara, Keiko; Sou, Keitaro; Takeoka, Shinji.

:: Frontiers in Bioengineering and Biotechnology, 巻 7, 番号 APR, 77, 01.01.2019.

研究成果: Article

@article{28650dba8d264f04834913c1397509da,
title = "An assay to evaluate the function of liposomal platelet substitutes delivered to platelet aggregates",
abstract = "Aggregation of liposomal platelet substitutes with activated platelets is the primary endpoint to estimate hemostatic potential. Although light transmission aggregometry is a {"}gold standard{"} in assessing platelet aggregation in vitro, this method is less specific and sensitive when tested using liposomal platelet substitutes. In the current study, a new method is developed to evaluate the function of platelet substitutes. By labeling liposomes with a fluorescent dye, DiD, we evaluated their ability to target platelet aggregates using a fluorescence microscope. By incorporating an image-based 96 microtiter microplate, this method was optimized by varying the final lipid concentrations and washing times and validated using unmodified liposomes (e.g., L550 with 0 mol{\%} of carboxylic headgroup lipid; L551 with 9 mol{\%} of carboxylic headgroup lipid) and modified liposomes (e.g., H12-L551 with 9 mol{\%} of carboxylic headgroup lipid and 0.3 mol{\%} of dodecapeptide). Our results showed that 200 μM of H12-L551 liposomes and four washes represent optimal conditions for quantitative fluorescence imaging. This method allowed users to qualitatively observe the fluorescently labeled liposomes involved in platelet aggregates. The imaging analysis tool was sufficiently sensitive to quantitatively determine the significantly enhanced delivery of the modified liposomes to platelet aggregates. This enhancement was achieved using dodecapeptide, which specifically binds to activated platelets. This robust and high-throughput method enables the evaluation of liposome function and should facilitate the development of platelet substitutes with a greater ability to target platelet aggregates.",
keywords = "Fluorescence, Imaging techniques, Liposomes, Microscopy, Nanoparticles, Platelet aggregation, Platelet substitutes",
author = "Tan, {Suyun Janet} and Keiko Nakahara and Keitaro Sou and Shinji Takeoka",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fbioe.2019.00077",
language = "English",
volume = "7",
journal = "Frontiers in Bioengineering and Biotechnology",
issn = "2296-4185",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - An assay to evaluate the function of liposomal platelet substitutes delivered to platelet aggregates

AU - Tan, Suyun Janet

AU - Nakahara, Keiko

AU - Sou, Keitaro

AU - Takeoka, Shinji

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Aggregation of liposomal platelet substitutes with activated platelets is the primary endpoint to estimate hemostatic potential. Although light transmission aggregometry is a "gold standard" in assessing platelet aggregation in vitro, this method is less specific and sensitive when tested using liposomal platelet substitutes. In the current study, a new method is developed to evaluate the function of platelet substitutes. By labeling liposomes with a fluorescent dye, DiD, we evaluated their ability to target platelet aggregates using a fluorescence microscope. By incorporating an image-based 96 microtiter microplate, this method was optimized by varying the final lipid concentrations and washing times and validated using unmodified liposomes (e.g., L550 with 0 mol% of carboxylic headgroup lipid; L551 with 9 mol% of carboxylic headgroup lipid) and modified liposomes (e.g., H12-L551 with 9 mol% of carboxylic headgroup lipid and 0.3 mol% of dodecapeptide). Our results showed that 200 μM of H12-L551 liposomes and four washes represent optimal conditions for quantitative fluorescence imaging. This method allowed users to qualitatively observe the fluorescently labeled liposomes involved in platelet aggregates. The imaging analysis tool was sufficiently sensitive to quantitatively determine the significantly enhanced delivery of the modified liposomes to platelet aggregates. This enhancement was achieved using dodecapeptide, which specifically binds to activated platelets. This robust and high-throughput method enables the evaluation of liposome function and should facilitate the development of platelet substitutes with a greater ability to target platelet aggregates.

AB - Aggregation of liposomal platelet substitutes with activated platelets is the primary endpoint to estimate hemostatic potential. Although light transmission aggregometry is a "gold standard" in assessing platelet aggregation in vitro, this method is less specific and sensitive when tested using liposomal platelet substitutes. In the current study, a new method is developed to evaluate the function of platelet substitutes. By labeling liposomes with a fluorescent dye, DiD, we evaluated their ability to target platelet aggregates using a fluorescence microscope. By incorporating an image-based 96 microtiter microplate, this method was optimized by varying the final lipid concentrations and washing times and validated using unmodified liposomes (e.g., L550 with 0 mol% of carboxylic headgroup lipid; L551 with 9 mol% of carboxylic headgroup lipid) and modified liposomes (e.g., H12-L551 with 9 mol% of carboxylic headgroup lipid and 0.3 mol% of dodecapeptide). Our results showed that 200 μM of H12-L551 liposomes and four washes represent optimal conditions for quantitative fluorescence imaging. This method allowed users to qualitatively observe the fluorescently labeled liposomes involved in platelet aggregates. The imaging analysis tool was sufficiently sensitive to quantitatively determine the significantly enhanced delivery of the modified liposomes to platelet aggregates. This enhancement was achieved using dodecapeptide, which specifically binds to activated platelets. This robust and high-throughput method enables the evaluation of liposome function and should facilitate the development of platelet substitutes with a greater ability to target platelet aggregates.

KW - Fluorescence

KW - Imaging techniques

KW - Liposomes

KW - Microscopy

KW - Nanoparticles

KW - Platelet aggregation

KW - Platelet substitutes

UR - http://www.scopus.com/inward/record.url?scp=85064603724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064603724&partnerID=8YFLogxK

U2 - 10.3389/fbioe.2019.00077

DO - 10.3389/fbioe.2019.00077

M3 - Article

AN - SCOPUS:85064603724

VL - 7

JO - Frontiers in Bioengineering and Biotechnology

JF - Frontiers in Bioengineering and Biotechnology

SN - 2296-4185

IS - APR

M1 - 77

ER -